Decoy Therapeutics Inc DCOY
$3.20 $0.08 (2.44%) 1D
Last Updated: Aug 21, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
DCOY Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Decoy Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Decoy Therapeutics Inc. Stock Analysis DCOY
United States Health Care Nano Cap Decoy Therapeutics, Inc. operates as a preclinical-stage biotechnology company. The company is headquartered in Houston, Texas and currently employs 11 full-time employees. The company went IPO on 2015-01-29. The Company’s initial pipeline is focused on respiratory viruses and GI cancers. In parallel, the Company is advancing discovery programs, including multi-virus decoy candidates designed to address overlapping respiratory threats, and cell-based and organoid-level validation of novel G protein-coupled receptor (GPCR)-targeted drug candidates outside of antivirals.
Decoy Therapeutics Inc (DCOY) Chart
Financial Metrics & Statements of Decoy Therapeutics Inc (DCOY)
FAQ's for Decoy Therapeutics Inc (DCOY)
- As of August 2026, Decoy Therapeutics Inc DCOY is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Decoy Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Decoy Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Decoy Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Decoy Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Decoy Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Decoy Therapeutics Inc (DCOY)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
